How many institutions own SLRX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SLRX shares is 10, representing 6.57% of the company's common stock.

Who are the major shareholders selling Salarius Pharmaceuticals, Inc. stock?

UBS GROUP AG, in the last quarter, reduced its stake in SLRX by -3.4% restricting it's holding to 40.85 thousand shares of worth nearly $8.00K. HIGHTOWER ADVISORS, LLC also lessened -100% of the SLRX shares from its portfolio, reducing its holding to 0 shares of worth -. MILLENNIUM MANAGEMENT LLC also shunned SLRX shares holding by -60.37% last quarter which brought its holding to 115.68 thousand shares worth $23.00K.

Investors who are buying SLRX stock?

As per its latest 13F filing, HORIZON KINETICS ASSET MANAGEMENT LLC increased its stake in SLRX by 50% in the last quarter. The institutional holder raised its holding to 60 thousand shares having worth more than $12.00K. MORGAN STANLEY also added 0.13% more shares of SLRX to its portfolio, raising its holding to 1.5 thousand shares of worth -. RENAISSANCE TECHNOLOGIES LLC also increased its SLRX shares holding by 17.88% which brought its holding to 634.26 thousand shares worth $124.00K.

SLRX's major insiders: who are they?

The insider with the most stakes in SLRX is Boston Foundation, Inc. , 10 percent owner at the company. Additionally, SLRX stock is highly held by director MacKinnon Roderick and director Northrup Jonathan P among others.

Did an insider recently sell SLRX stock?

Company executives, directors, and other insiders own 1.7% percent of Salarius Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which SLRX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include BOSTON FOUNDATION, INC., WESTPHAL CHRISTOPH H, and LONGWOOD FUND II, L.P..

Which insider recently purchased SLRX stock?

There have been 0 transaction(s) during the past 6-months in which Salarius Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

How much of SLRX does insiders own?

Around 0 Salarius Pharmaceuticals, Inc. shares are held by insiders, which represents about 1.7% of SLRX stock.

Who is the insider with the largest stake?

SLRX 10 percent owner, Boston Foundation, Inc. holds the largest portfolio of the company's shares. SLRX shares owned by Boston total nearly 1.6 million.

Which institution holds the most shares in SLRX?

STATE STREET CORP is the largest institutional owner in SLRX which holds 142.55 thousand shares worth $28.00K or 0.25% of the total SLRX shares outstanding followed by UBS GROUP AG with ownership of 40.85 thousand shares representing 0.07% of the SLRX ownership. HIGHTOWER ADVISORS, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Salarius Pharmaceuticals, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SLRX is concerned, it is a stock which is not optionable.

Is there a short position on SLRX's shares?

Number of SLRX shares short is 47.99K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding SLRX shares are there?

As of today, 2.13M shares of SLRX are outstanding.

Is there many float in SLRX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SLRX has 2.09M shares in float.

SLRX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SLRX is 1.67.

Salarius Pharmaceuticals (SLRX) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares2.26

Short Percent Of Float2.27

Shares Outstanding2.13M

Shares Float2.09M

Shares Short47.99K

Short Ratio1.67

2.27%

Short % of Float

2.26%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

1.7% Percentage of Shares held by All Insiders

6.57% Percentage of Shares held by All Institutions

6.69% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 6.57% of SLRX shares are held by financial institutions. STATE STREET CORP is the top corporate investor, holding 142.55K shares valued at $28.00K. A 0.25% stake in Salarius Pharmaceuticals, Inc. is owned by the company. UBS GROUP AG owns 40.85K shares valued at $8.00K, which translates its holding of 0.07% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Sep 30, 2022	STATE STREET CORP	0.25%	142.55K	28K	0	0
Sep 30, 2022	UBS GROUP AG	0.07%	40.85K	8K	-1.44K	-3.40%
Sep 30, 2022	HIGHTOWER ADVISORS, LLC	0%	0	-	-26.55K	-100.00%
Sep 30, 2022	MILLENNIUM MANAGEMENT LLC	0.21%	115.68K	23K	-176.22K	-60.37%
Sep 30, 2022	CAPTRUST FINANCIAL ADVISORS	0%	0	-	-1K	-100.00%
Sep 30, 2022	CITADEL ADVISORS LLC	0%	0	-	-166.03K	-100.00%
Sep 30, 2022	X-SQUARE CAPITAL, LLC	0.16%	89K	17K	0	0
Sep 30, 2022	NORTHERN TRUST CORP	0.12%	65.02K	13K	0	0
Sep 30, 2022	HORIZON KINETICS ASSET MANAGEMENT LLC	0.11%	60K	12K	20K	+50.00%
Sep 30, 2022	WETHERBY ASSET MANAGEMENT INC	0.07%	39.75K	8K	0	0
Sep 30, 2022	BANK OF NEW YORK MELLON CORP	0.06%	35.27K	7K	0	0
Sep 30, 2022	ADVISOR GROUP HOLDINGS, INC.	0.06%	34.7K	6K	-4	-0.01%
Sep 30, 2022	ERN FINANCIAL, LLC	0.06%	32.05K	6K	0	0
Sep 30, 2022	TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	24.09K	5K	-55.12K	-69.59%
Sep 30, 2022	CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	0.04%	21.29K	4K	0	0
Sep 30, 2022	TWO SIGMA SECURITIES, LLC	0.02%	12.19K	2K	-3.31K	-21.35%
Sep 30, 2022	LPL FINANCIAL LLC	0.02%	10.02K	2K	0	0
Sep 30, 2022	MORGAN STANLEY	0%	1.5K	-	2	+0.13%
Sep 30, 2022	BLACKROCK INC.	0%	1.2K	-	0	0
Sep 30, 2022	WELLS FARGO & COMPANY/MN	0%	350	-	-25	-6.67%
Sep 30, 2022	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Sep 30, 2022	VANGUARD GROUP INC	2.41%	1.35M	264K	-231.65K	-14.61%
Sep 30, 2022	RENAISSANCE TECHNOLOGIES LLC	1.13%	634.26K	124K	96.2K	+17.88%
Sep 30, 2022	GEODE CAPITAL MANAGEMENT, LLC	0.74%	413.14K	80K	0	0
Sep 30, 2022	TWO SIGMA ADVISERS, LP	0.55%	310K	60K	-16.2K	-4.97%
Sep 30, 2022	FINANCIAL ADVOCATES INVESTMENT MANAGEMENT	0%	0	-	-11.47K	-100.00%
Sep 30, 2022	VIRTU FINANCIAL LLC	0%	0	-	-82.17K	-100.00%

Insiders

Among the SLRX insiders holding of 1.7% of the stake in company, BOSTON FOUNDATION, INC., 10 percent owner, holds the largest shares of 1.6M. MACKINNON RODERICK, director, is the second largest SLRX insider with ownership of 431.28K shares. NORTHRUP JONATHAN P, director, stands third with possession of 352.71K shares of that stake.

Insiders	Designation	Shares Held
BOSTON FOUNDATION, INC.	10 percent owner	1.6M
MACKINNON RODERICK	director	431.28K
NORTHRUP JONATHAN P	director	352.71K
ARTHUR DAVID J.	Chief Executive Officer	263.07K
ROSENBLUM MARK J	Exec VP Finance, CFO	148.32K
WESSEL THOMAS	Chief Medical Officer	57.06K
HANISH ARNOLD C		46.35K
LIEBER JONATHAN I		37.5K
BURLESON TESS		32.05K
JORDAN SCOTT	Chief Business Officer	31.61K
MCVICAR WILLIAM K.		26.55K
MCCREEDY BRUCE J JR.	director	8.7K
SCULLEY JOHN	director	4.71K
STACY MICHELLE	director	2.59K
MCCABE JOHN P.	VP of Finance & Treasurer	1.65K
LONGWOOD FUND II, L.P.	10 percent owner	0
WESTPHAL CHRISTOPH H	10 percent owner	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jun 07, 2022	BURLESON TESS	PURCHASE	0.18	27.7K	4.99K	32.05K
Jun 07, 2022	LIEBER JONATHAN I	PURCHASE	0.19	37.5K	7.02K	37.5K
Jun 06, 2022	MCVICAR WILLIAM K.	PURCHASE	0.19	26.55K	5K	26.55K
Jun 03, 2022	HANISH ARNOLD C	PURCHASE	0.18	28K	5.15K	46.35K
May 31, 2022	ROSENBLUM MARK J	PURCHASE	0.18	28K	5.04K	148.32K
May 26, 2022	ARTHUR DAVID J.	PURCHASE	0.18	3.4K	612	263.07K
Mar 03, 2022	ROSENBLUM MARK J	PURCHASE	0.39	76.25K	29.81K	110.32K
Mar 03, 2022	ARTHUR DAVID J.	PURCHASE	0.39	139.49K	54.54K	249.67K
Aug 17, 2021	ARTHUR DAVID J.	PURCHASE	0.90	2K	1.8K	100.25K
Aug 10, 2021	HANISH ARNOLD C	PURCHASE	0.88	7K	6.17K	18.35K
Aug 21, 2020	HANISH ARNOLD C	PURCHASE	0.98	4K	3.92K	11.35K
Aug 19, 2020	ARTHUR DAVID J.	PURCHASE	1.01	1K	1.01K	1K
Aug 17, 2020	ROSENBLUM MARK J	PURCHASE	1.00	5K	5K	12K
Feb 19, 2020	ROSENBLUM MARK J	PURCHASE	0.95	2K	1.9K	7K
Feb 18, 2020	JORDAN SCOTT	PURCHASE	0.90	11.3K	10.17K	31.61K
Feb 13, 2020	ROSENBLUM MARK J	PURCHASE	0.86	5K	4.3K	5K
Feb 11, 2020	ARTHUR DAVID J.	PURCHASE	1.15	2.18K	2.5K	81.55K
Feb 11, 2020	MCVICAR WILLIAM K.	PURCHASE	1.15	8.7K	10.01K	8.7K
Feb 11, 2020	NORTHRUP JONATHAN P	PURCHASE	1.15	8.7K	10.01K	352.71K
Feb 11, 2020	HANISH ARNOLD C	PURCHASE	1.15	4.35K	5K	7.35K
Feb 11, 2020	MCCREEDY BRUCE J JR.	PURCHASE	1.15	8.7K	10.01K	8.7K
Feb 11, 2020	BURLESON TESS	PURCHASE	1.15	4.35K	5K	4.35K
Nov 25, 2019	HANISH ARNOLD C	PURCHASE	3.59	3K	10.77K	6K
Jan 09, 2019	BOSTON FOUNDATION, INC.	SALE	0.37	337K	123.85K	1.6M
Jan 08, 2019	BOSTON FOUNDATION, INC.	SALE	0.40	263K	104.31K	1.94M
Oct 16, 2018	WESTPHAL CHRISTOPH H	SALE	0.92	3.21M	2.94M	0
Oct 16, 2018	LONGWOOD FUND II, L.P.	SALE	0.92	3.21M	2.94M	0
Nov 08, 2016	WESTPHAL CHRISTOPH H	PURCHASE	7.31	7K	51.17K	3.94M
Nov 07, 2016	WESTPHAL CHRISTOPH H	PURCHASE	5.70	8.87K	50.56K	3.93M
Nov 07, 2016	MCCABE JOHN P.	PURCHASE	6.01	1.65K	9.92K	1.65K
Jun 23, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.28	2.7K	30.46K	3.21M
Jun 22, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.03	2.9K	31.99K	3.21M
Jun 21, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.07	2.8K	31K	3.21M
Jun 20, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.37	3K	34.11K	3.2M
Jun 17, 2016	WESTPHAL CHRISTOPH H	PURCHASE	10.98	3K	32.94K	3.2M
Jun 16, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.10	2.9K	32.19K	3.2M
Jun 15, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.24	2.9K	32.6K	3.2M
Jun 14, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.19	3K	33.57K	3.19M
Jun 13, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.90	2.9K	34.51K	3.19M
Jun 10, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.83	3K	35.49K	3.19M
Jun 09, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.04	3K	36.12K	3.18M
Jun 08, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.24	2.9K	35.5K	3.18M
Jun 07, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.26	3K	36.78K	3.18M
Jun 06, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.33	3K	36.99K	3.17M
Jun 03, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.79	3K	38.37K	3.17M
Jun 02, 2016	WESTPHAL CHRISTOPH H	PURCHASE	13.22	5K	66.1K	3.17M
Jun 01, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.76	5K	63.8K	3.16M
May 31, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.66	5K	63.3K	3.16M
May 27, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.68	17.3K	219.36K	3.15M
May 26, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.53	16.3K	204.24K	3.14M
May 25, 2016	WESTPHAL CHRISTOPH H	PURCHASE	13.25	12.3K	162.98K	3.12M
May 24, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.50	16.97K	212.09K	3.11M
May 23, 2016	WESTPHAL CHRISTOPH H	PURCHASE	12.31	13.37K	164.55K	3.09M
May 20, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.44	1K	11.44K	3.08M
May 19, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.00	6.91K	76.05K	3.08M
May 18, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.05	15.2K	167.96K	3.07M
May 17, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.14	18.2K	202.75K	3.05M
May 16, 2016	WESTPHAL CHRISTOPH H	PURCHASE	10.40	8.2K	85.28K	3.04M
May 13, 2016	WESTPHAL CHRISTOPH H	PURCHASE	10.09	7.27K	73.34K	3.03M
May 12, 2016	WESTPHAL CHRISTOPH H	PURCHASE	9.94	16.1K	160K	3.02M
May 11, 2016	WESTPHAL CHRISTOPH H	PURCHASE	10.33	14.12K	145.86K	3M
May 10, 2016	WESTPHAL CHRISTOPH H	PURCHASE	10.14	12.58K	127.53K	2.99M
May 09, 2016	WESTPHAL CHRISTOPH H	PURCHASE	9.80	17.53K	171.81K	2.98M
Mar 24, 2016	WESTPHAL CHRISTOPH H	PURCHASE	10.55	24.21K	255.38K	2.96M
Mar 23, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.55	25.36K	292.86K	2.94M
Mar 22, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.78	23.95K	282.14K	2.91M
Mar 21, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.70	24.11K	282.05K	2.89M
Mar 21, 2016	SCULLEY JOHN	PURCHASE	12.06	4K	48.24K	4.71K
Mar 18, 2016	WESTPHAL CHRISTOPH H	PURCHASE	11.06	18.44K	203.91K	2.86M
Mar 18, 2016	SCULLEY JOHN	PURCHASE	11.13	709	7.89K	709
Mar 17, 2016	WESTPHAL CHRISTOPH H	PURCHASE	10.94	19.14K	209.36K	2.84M
Mar 16, 2016	WESTPHAL CHRISTOPH H	PURCHASE	10.85	19.14K	207.69K	2.83M
Mar 15, 2016	STACY MICHELLE	PURCHASE	9.63	2.59K	24.89K	2.59K
Mar 15, 2016	WESTPHAL CHRISTOPH H	PURCHASE	9.62	19.24K	185.06K	2.81M
Mar 14, 2016	WESSEL THOMAS	PURCHASE	9.13	8K	73.04K	57.06K
Mar 11, 2016	WESSEL THOMAS	PURCHASE	7.15	12K	85.8K	49.06K
Mar 11, 2016	MACKINNON RODERICK	PURCHASE	7.03	10K	70.26K	431.28K
Mar 11, 2016	LONGWOOD FUND II, L.P.	PURCHASE	7.00	89.68K	627.76K	2.79M
Mar 11, 2016	WESTPHAL CHRISTOPH H	PURCHASE	7.00	89.68K	627.76K	2.79M
Dec 14, 2015	WESTPHAL CHRISTOPH H	PURCHASE	12.01	927	11.13K	3.93M
Dec 07, 2015	WESTPHAL CHRISTOPH H	PURCHASE	12.02	907	10.9K	3.92M
Nov 30, 2015	WESTPHAL CHRISTOPH H	PURCHASE	12.32	887	10.93K	3.92M
Nov 23, 2015	WESTPHAL CHRISTOPH H	PURCHASE	11.39	971	11.06K	3.92M

Frequently Asked Questions